Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,671 | -2,886 | N/A | -1,060 | -764 |
| Depreciation Amortization | 808 | 361 | N/A | 899 | 560 |
| Other Working Capital | -2,699 | -2,184 | N/A | -4,710 | -4,991 |
| Other Operating Activity | 382 | 339 | 0 | 131 | 131 |
| Operating Cash Flow | $-6,179 | $-4,371 | $N/A | $-4,740 | $-5,065 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,497 | 6,541 | N/A | 21,019 | 17,206 |
| PPE Investments | -4,850 | -2,120 | N/A | -8,591 | -1,475 |
| Investing Cash Flow | $8,647 | $4,422 | $N/A | $12,428 | $15,731 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -70 | -70 |
| Common Stock Issued | 1 | N/A | N/A | 749 | 531 |
| Financing Cash Flow | $1 | $N/A | $N/A | $679 | $461 |
| Beginning Cash Position | 13,063 | 13,063 | N/A | 8,608 | 8,608 |
| End Cash Position | 15,532 | 13,114 | N/A | 16,975 | 19,736 |
| Net Cash Flow | $2,469 | $51 | $N/A | $8,367 | $11,128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,179 | -4,371 | N/A | -4,740 | -5,065 |
| Capital Expenditure | -4,850 | -2,120 | N/A | -8,591 | -1,475 |
| Free Cash Flow | -11,029 | -6,490 | 0 | -13,330 | -6,540 |